Corbus Pharmaceuticals Holdings, Inc. ( CRBP) - Stock Earnings

CRBP Quarterly earnings

Analyst consensus estimates are available to paid members.

DateEarningsRevenue
2025Q3 -23.3 million USD — USD
2025Q4 -20.6 million USD — USD
2026Q1 -23.0 million USD — USD
2026Q2 Est.
2026Q3 Est.
2026Q4 Est.

CRBP Yearly earnings

Analyst consensus estimates are available to paid members.

DateEarningsRevenue
2023 -44.6 million USD — USD
2024 -40.2 million USD — USD
2025 -78.5 million USD — USD
2026 Est.

CRBP

Price: $8.26

52 week price:
6.72
20.56

Earnings Per Share: -5.74 USD

Exchange: NCM

Sector: Healthcare

Industry: Biotechnology

Country: United States

Volume: 1.8 million

Ebitda: -6.8 million

Market Capitalization: 94.8 million

Links: